Doximity, Inc.
DOCS
Positions held
Your positionsDOCS isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Doximity operates in a growing healthcare technology sector, providing essential services to healthcare professionals, which positions it well against competitors.
- In Q2 2026, Doximity reported a revenue increase of 8% compared to the previous quarter, reaching $157 million.
- The company has a strong operating margin of 21.5%, indicating efficient management of its resources.
- Despite its growth, Doximity faces challenges with a significant earnings decline of 51.9% year-over-year.
- The trailing P/E ratio stands at 33.48, suggesting the stock may be overvalued compared to its earnings growth.
- The company's net income decreased to $24.3 million in Q2 2026, down from $19.1 million in Q1 2026.
Fundamentals
| Market cap | $5.24B | Enterprise value | $4.56B | Trailing P/E | 34.56 | Forward P/E | 18.87 |
| PEG | 0.59 | Price / book | 5.77 | Beta | 1.22 | Dividend yield | 0.00% |
| Revenue growth | 7.3% | Earnings growth | -51.9% | Gross margin | 88.1% | Operating margin | 21.5% |
| Profit margin | 25.5% | ROE | 17.2% | ROA | 10.9% | Debt / equity | 0.01 |
| Current ratio | 6.08 | Free cash flow | $239.70M | Analyst recommendation | hold | Mean target | $29.67 |
| 52w high | $72.24 | 52w low | $17.15 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | — |
| Op margin | 21.5% | 17.1% | 38.9% | 37.8% | 37.4% | — |
| Net income | $24.3M | $19.1M | $61.6M | $62.1M | $53.3M | — |
| Gross margin | 84.9% | 86.7% | 89.9% | 90.3% | 89.2% | — |
| Gross profit | $133M | $126M | $166M | $152M | $130M | — |
| Operating income | $33.6M | $24.8M | $71.9M | $63.7M | $54.5M | — |
- Revenue +8% vs prior quarter ($157M vs $145M).
- Gross margin 84.9% (was 86.7% prior quarter).
- Operating margin expanded to 21.5%.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | — |
| Op margin | 33.3% | 40.3% | 36.1% | 29.9% | — |
| Net income | $196M | $223M | $148M | $113M | — |
| Gross margin | 89.1% | 90.2% | 89.3% | 87.2% | — |
| Gross profit | $575M | $515M | $425M | $366M | — |
| Operating income | $215M | $230M | $172M | $125M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Is Doximity (DOCS) Below Fair Value Following The AI Spending Surge?
2026-10-08 · Palantir Technologies, Doximity, Snowflake, and Teradata Shares Skyrocket, What You Need To Know
2026-10-05 · Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
2026-10-05 · Reasons to Retain Doximity Stock in Your Portfolio for Now
2026-09-30 · UiPath, monday.com, Amplitude, Doximity, and Sprinklr Shares Skyrocket, What You Need To Know
2026-09-29 · Doximity (DOCS) Gains As Market Dips: What You Should Know
2026-09-24 · Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
2026-09-24 · 3 Profitable Stocks with Warning Signs
2026-09-23 · What Doximity (DOCS)'s Bedside Bench AI Benchmark Launch Means For Shareholders
2026-09-22 · Doximity Named Leading Clinical AI Benchmark in Fireworks’ Cross-Industry Index
2026-09-21 · Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
2026-09-15 · Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Price (daily)
Full chart · RSI · MACD · patterns